However, the same pathogenic variant has been detected in patients with different clinical manifestations (6), suggesting the role of genetic modifiers, such as variants in genes encoding for protein partners of FOXP3, and epigenetic factors in determining the expressivity of IPEX syndrome (6, 7). This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.